Olema Pharmaceuticals, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
OLMA Company Description
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
OLMA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view OLMA Smart Score
Score Breakdown
OLMA Company Description
Show More
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of OLMA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by OLMA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of OLMA in WallStreetBets Daily Discussion
OLMA News
Recent insights relating to OLMA
CNBC Recommendations
Recent picks made for OLMA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in OLMA
Corporate Flights
Flights by private jets registered to OLMA
Our Analysis